
Podcast
A Good Night’s Sleep: The Possible Association Between the Early Introduction of Food and Infant Sleep - Frankly Speaking EP 90
Both the WHO and AAP recommend exclusive breastfeeding until 6 months of age then solids and breast milk until 12 months of age. The well-established benefits of breastfeeding include support of infant growth and development of immunity. Recently, a clinical trial from the UK found an association between the early introduction of foods and infant sleep. Join us while we discuss the findings of this study and possible implications to your care of moms and their infants.
- AAP Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents,4th Edition. https://brightfutures.aap.org/materials-and-tools/guidelines-and-pocket-guide/Pages/default.aspx
- American Academy of Pediatrics Committee on Nutrition. Complementary feeding. In: Pediatric Nutrition, 7th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2014. p.123.
- Kleinman RE, Coletta FA. Historical Overview of Transitional Feeding Recommendations and Vegetable Feeding Practices for Infants and Young Children. Nutrition Today. 2016;51(1):7-13. doi:10.1097/NT.0000000000000137.
- Kuo AA, Inkelas M, Slusser WM, Maidenberg M, Halfon N. Introduction of Solid Food to Young Infants. Maternal and Child Health Journal. 2011;15(8):1185-1194. doi:10.1007/s10995-010-0669-5.
- Perkin MR, Bahnson HT, Logan K, et al. Association of Early Introduction of Solids With Infant Sleep: A Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr. 2018;172(8):e180739. doi:10.1001/jamapediatrics.2018.0739
- https://jamanetwork.com/journals/jamapediatrics/fullarticle/2686726?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert&utm_term=mostread&utm_content=olf-widget_08272018
- Schwarzenberg SJ, Georgieff MK, AAP COMMITTEE ON NUTRITION. Advocacy for Improving Nutrition in the First 1000 Days To Support Childhood Development and Adult Health. Pediatrics. 2018;141(2):e20173716
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 10/15/2018
Expiration Date: 10/15/2019
Topics
Faculty

Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
A. Susan Feeney, APRN,BC
Learn MoreDisclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Frank J. Domino, MD: Has disclosed no relevant financial relationships.
Susan Feeney, DNP, FNP-BC: Has disclosed no relevant financial relationships.
Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.